An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury
- Disease/Condition
- Traumatic Brain Injury
- Study type
- Observational
- Primary sponsor
- Power Life Sciences Inc.
- Location
- San Francisco, United States of America
- Phase
- N/A
- Start date
- Mar 01, 2025
- End date
- Mar 01, 2027
- Enrollment
- 500 participants
Number of patients who decide to enroll in a traumatic brain injury clinical trial,Rate of patients who remain in traumatic brain injury clinical trial to trial completion
Clinical study participation has historically been heavily biased toward specific
 demographics.
 
 Several people will be invited to enroll in this study so that it may collect a variety of
 data about traumatic brain injury clinical trial experiences and identify barriers to
 participation as well as the causes of participants' failure or withdrawal.
 
 People with traumatic brain injury who are invited to take part in medical research will
 benefit from the analysis of the data.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06264518
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06264518 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Traumatic Brain Injury. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.